Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes

NCT00382096 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1179

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Vildagliptin
DRUG: Metformin
DRUG: Vildagliptin + Metformin

Sponsor

Novartis Pharmaceuticals